Option chain shows key data for Alibaba Health Info Tech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Alibaba Health Info Tech.

Alibaba Health Info Tech (OTC:ALBBY) Stock, Option Chain

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer," although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Asia

Markets

General

ALBBY

JDHIF

Key Takeaways:


	The gross margin on the company’s proprietary drug distribution business, its main revenue source, edged down to 6.1% last year
	With the pharma market already well developed, several distribution giants have muscled onto YSB’s turf as suppliers to pharmacies and smaller clinics


By Molly Wen

Slowing Revenue Growth Hurts Online Drug Platform YSB

ALIBABA HEALTH UNSP/ADR by Alibaba Health Information Technology Ltd

Comments

Alibaba Health Info Tech

Alibaba Health Info Tech (ALBBY) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell